日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gut Microbiome Signatures Distinguish Susceptibility from Disease Development in Type 2 Diabetes

肠道微生物组特征可区分2型糖尿病的易感性和疾病发展

Ifrach, Chen; Levy-Turgeman, Ruth; Szitenberg, Amir; Kesten, Inbar; Pitashny, Milena; Levin-Iaina, Nomy; Segev, Yael; Yagil, Yoram

Expanded Hemodialysis with Theranova 500 Improves Dialysis Adequacy and Blunts Inflammation: A 24-Week Quasi-Randomized Trial

使用 Theranova 500 进行扩大血液透析可提高透析充分性并减轻炎症:一项为期 24 周的准随机试验

Levin Iaina, Nomy; Rotshild, Elena; Mini Goldberg, Sharon; Beckerman, Pazit

Real-world implementation of the 2020 KDIGO guidelines for diabetes management in chronic kidney disease: a single-center retrospective study

2020年KDIGO指南在慢性肾脏病糖尿病管理中的实际应用:一项单中心回顾性研究

Levin-Iaina, Nomy; El'Nasasra, Hatem; Reiner-Benaim, Anat

Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine

辉瑞-BioNTech新冠疫苗接种后出现的微小病变疾病

Lebedev, Larissa; Sapojnikov, Marina; Wechsler, Alexander; Varadi-Levi, Ronen; Zamir, Doron; Tobar, Ana; Levin-Iaina, Nomy; Fytlovich, Shlomo; Yagil, Yoram

Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis.

接受腹膜透析治疗的难治性充血性心力衰竭患者的炎症生物标志物

Kunin Margarita, Carmon Vered, Arad Michael, Levin-Iaina Nomy, Freimark Dov, Holtzman Eli J, Dinour Dganit